Tamoxifen Alters the Plasma Concentration of Molecules Associated with Cardiovascular Risk in Women with Breast Cancer Undergoing Chemotherapy

OBJECTIVES. The objective of this study was to evaluate the effect of tamoxifen on blood markers that are associated with cardiovascular risk, such as C-reactive protein (CRP), apolipoprotein A-1 (Apo-A), and apolipoprotein B-100 (Apo-B), in women undergoing chemotherapy for breast cancer. METHODS....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Romero, Walckiria G., Da Silva, Fabrício B., Borgo, Mariana V., Bissoli, Nazaré S., Gouvêa, Sonia A., Abreu, Gláucia R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: AlphaMed Press 2012
Soggetti:
Breast Cancer
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3336829/
https://ncbi.nlm.nih.gov/pubmed/22491005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0369
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi